Taconic Biosciences Launches New Inflammatory Bowel Disease Models
RENSSELAER, N.Y., April 19, 2018 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions, announces the launch of several new inflammatory bowel disease (IBD) animal models.
As a fully-licensed provider of CRISPR/Cas9 gene editing technology, Taconic scientists knocked out the mouse Il10 gene to generate a spontaneous colitis mouse models. The new knockout models were created on Taconic's B6 (C57BL/6NTac) and BALB/c (BALB/cAnNTac) backgrounds, and are available at both the Excluded Flora (EF) and Germ Free (GF) health standards . Beyond the scientific benefits, Taconic is also making them easy to access by offering these models to commercial, contract research organization (CRO), and academic institutions under a simple label license. This represents a departure from the license requirements for Il10 knockouts from other animal model providers.
"In order for animal models to drive drug discovery they need to be both scientifically sound and accessible to the research community. Taconic checks both of those boxes with the launch of these Il10 knockouts, underscoring the company's extensive metabolic and microbiome portfolio and commitment to providing our customers with the best animal model solutions to accelerate discoveries for the prevention and treatment of disease," commented Dr. Michael Seiler, vice president of commercial products.
The Taconic IBD portfolio includes standard strains such as the B6 for chemically-induced colitis, Rag2 knockouts or C.B-17 scids for adoptive transfer colitis, and MDR1A for spontaneous colitis. Additionally, Taconic also supports metabolic research through an extensive portfolio of microbiome products and services . Launching these Il10 knockouts underscores Taconic's leadership providing solutions in the metabolic disease field. According to the CDC, between 1 and 1.3 million people suffer from IBD in the United States (https://www.cdc.gov/ibd/ibd-epidemiology.htm ), with global prevalence a major focus for the pharmaceutical industry, representing a significant market opportunity.
To learn more about how Taconic's animal model solutions can progress your research, please call 1-888-TACONIC ( 888-822-6642 ) in the US, +45 70 23 04 05 in Europe, or email email@example.com .
About Taconic Biosciences, Inc.
Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions so that customers can acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, precision research mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.
Kelly Owen Grover
Director of Marketing Communications
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Globenewswire
Vricon24.6.2019 14:32:47 CEST | Pressemeddelelse
U.S. Army awards Vricon contract for One World Terrain
Erytech Pharma S.A.24.6.2019 07:32:40 CEST | Pressemeddelelse
ERYTECH Announces Opening of Operations at its New Princeton, NJ GMP Manufacturing Facility
Wildflower Brands Inc.21.6.2019 14:32:20 CEST | Pressemeddelelse
Wildflower Featured in NetworkNewsWire Publication Summarizing Amazing Profits Found in Cannabis
ADC Therapeutics SA21.6.2019 07:02:09 CEST | Pressemeddelelse
ADC Therapeutics Presents Clinical Data on ADCT-402 and ADCT-301 in Subtypes of Relapsed or Refractory Lymphoma at the 15th International Conference on Malignant Lymphoma
TriLumina20.6.2019 19:02:26 CEST | Pressemeddelelse
TriLumina Launches the World’s First Surface-Mount Flip-Chip Back-Emitting VCSEL Array Without the Need for a Submount
Appian Corporation19.6.2019 16:30:17 CEST | Pressemeddelelse
Appian Named A Leader in Digital Process Automation for Deep Deployments Report by Independent Research Firm
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum